Form 4 for ASND Ascendis Pharma A/S
Accepted 2026-05-12 16:08:41 ET · period of report 2026-05-11 · accession 0001610717-26-000159 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-12 16:08 | 2026-05-11 | ASND | JENSEN FLEMMING STEEN | See Remarks | S - Sale | $238.49 | -19.5K | 0 | -100% | -$4.64M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-05-11 | S | D | 19,460 | $238.49 | 0 | D | — | — |